Viability and apoptosis measured by imaging in BRAF(V600E/D) melanoma cell lines following treatment with combinations of two compounds (viability/apoptosis dataset 1 of 2) - Dataset (ID:20272)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule 1 | Small Molecule 2 | Small Mol 1 Concentration | Small Mol 2 Concentration | Small Mol Conc Unit | Time Point | Time Point Unit | Replicate | Total Number of Cells (Nuclei) | Number of Apoptotic Cells | Relative Viability | Mean Relative Viability | Apoptosis Fraction | Mean Apoptosis Fraction |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
A-375 | Vemurafenib | Dasatinib | 0.000 | 0.000 | uM | 72 | hr | 1 | 19971 | 929 | 0.9642 | 1.0000 | 0.0465 | 0.0504 |
A-375 | Vemurafenib | Dasatinib | 0.000 | 0.000 | uM | 72 | hr | 2 | 20940 | 1098 | 1.0048 | 1.0000 | 0.0524 | 0.0504 |
A-375 | Vemurafenib | Dasatinib | 0.000 | 0.000 | uM | 72 | hr | 3 | 21481 | 1121 | 1.0310 | 1.0000 | 0.0522 | 0.0504 |
A-375 | Vemurafenib | Dasatinib | 0.000 | 0.316 | uM | 72 | hr | 1 | 5949 | 318 | 0.2851 | 0.2714 | 0.0535 | 0.0654 |
A-375 | Vemurafenib | Dasatinib | 0.000 | 0.316 | uM | 72 | hr | 2 | 5334 | 374 | 0.2512 | 0.2714 | 0.0701 | 0.0654 |
A-375 | Vemurafenib | Dasatinib | 0.000 | 0.316 | uM | 72 | hr | 3 | 5915 | 430 | 0.2777 | 0.2714 | 0.0727 | 0.0654 |
A-375 | Vemurafenib | Dasatinib | 0.000 | 1.000 | uM | 72 | hr | 1 | 3016 | 167 | 0.1443 | 0.1539 | 0.0554 | 0.0544 |
A-375 | Vemurafenib | Dasatinib | 0.000 | 1.000 | uM | 72 | hr | 2 | 3284 | 186 | 0.1569 | 0.1539 | 0.0566 | 0.0544 |
A-375 | Vemurafenib | Dasatinib | 0.000 | 1.000 | uM | 72 | hr | 3 | 3339 | 171 | 0.1604 | 0.1539 | 0.0512 | 0.0544 |
A-375 | Vemurafenib | Dasatinib | 0.000 | 3.160 | uM | 72 | hr | 1 | 4220 | 165 | 0.2053 | 0.1658 | 0.0391 | 0.0359 |
A-375 | Vemurafenib | Dasatinib | 0.000 | 3.160 | uM | 72 | hr | 2 | 3068 | 107 | 0.1499 | 0.1658 | 0.0349 | 0.0359 |
A-375 | Vemurafenib | Dasatinib | 0.000 | 3.160 | uM | 72 | hr | 3 | 2902 | 98 | 0.1420 | 0.1658 | 0.0338 | 0.0359 |
A-375 | Vemurafenib | Dasatinib | 0.100 | 0.000 | uM | 72 | hr | 1 | 7790 | 111 | 0.3888 | 0.4180 | 0.0142 | 0.0173 |
A-375 | Vemurafenib | Dasatinib | 0.100 | 0.000 | uM | 72 | hr | 2 | 8744 | 163 | 0.4345 | 0.4180 | 0.0186 | 0.0173 |
A-375 | Vemurafenib | Dasatinib | 0.100 | 0.000 | uM | 72 | hr | 3 | 8666 | 164 | 0.4305 | 0.4180 | 0.0189 | 0.0173 |
A-375 | Vemurafenib | Dasatinib | 0.100 | 0.316 | uM | 72 | hr | 1 | 3389 | 65 | 0.1683 | 0.1709 | 0.0192 | 0.0246 |
A-375 | Vemurafenib | Dasatinib | 0.100 | 0.316 | uM | 72 | hr | 2 | 3458 | 92 | 0.1704 | 0.1709 | 0.0266 | 0.0246 |
A-375 | Vemurafenib | Dasatinib | 0.100 | 0.316 | uM | 72 | hr | 3 | 3533 | 99 | 0.1739 | 0.1709 | 0.0280 | 0.0246 |
A-375 | Vemurafenib | Dasatinib | 0.100 | 1.000 | uM | 72 | hr | 1 | 2680 | 77 | 0.1318 | 0.1200 | 0.0287 | 0.0313 |
A-375 | Vemurafenib | Dasatinib | 0.100 | 1.000 | uM | 72 | hr | 2 | 2276 | 92 | 0.1106 | 0.1200 | 0.0404 | 0.0313 |
A-375 | Vemurafenib | Dasatinib | 0.100 | 1.000 | uM | 72 | hr | 3 | 2383 | 59 | 0.1177 | 0.1200 | 0.0248 | 0.0313 |
A-375 | Vemurafenib | Dasatinib | 0.100 | 3.160 | uM | 72 | hr | 1 | 2327 | 89 | 0.1133 | 0.0917 | 0.0382 | 0.0407 |
A-375 | Vemurafenib | Dasatinib | 0.100 | 3.160 | uM | 72 | hr | 2 | 1659 | 68 | 0.0806 | 0.0917 | 0.0410 | 0.0407 |
A-375 | Vemurafenib | Dasatinib | 0.100 | 3.160 | uM | 72 | hr | 3 | 1677 | 72 | 0.0813 | 0.0917 | 0.0429 | 0.0407 |
A-375 | Vemurafenib | Dasatinib | 0.316 | 0.000 | uM | 72 | hr | 1 | 5034 | 110 | 0.2493 | 0.2652 | 0.0219 | 0.0225 |